Moonlighting chromatin: when DNA escapes nuclear control

  • Jeeshan Singh
  • Michael Boettcher
  • Maximilian Dölling
  • Annika Heuer
  • Bettina Hohberger
  • Moritz Leppkes
  • Elisabeth Naschberger
  • Mirco Schapher
  • Christine Schauer
  • Janina Schoen
  • Michael Stürzl
  • Ljubomir Vitkov
  • Han Wang
  • Leticija Zlatar
  • Georg A. Schett
  • David S. Pisetsky (Shared last author)
  • Ming-Lin Liu (Shared last author)
  • Martin Herrmann (Shared last author)
  • Jasmin Knopf (Shared last author)

Abstract

Extracellular chromatin, for example in the form of neutrophil extracellular traps (NETs), is an important element that propels the pathological progression of a plethora of diseases. DNA drives the interferon system, serves as autoantigen, and forms the extracellular scaffold for proteins of the innate immune system. An insufficient clearance of extruded chromatin after the release of DNA from the nucleus into the extracellular milieu can perform a secret task of moonlighting in immune-inflammatory and occlusive disorders. Here, we discuss (I) the cellular events involved in the extracellular release of chromatin and NET formation, (II) the devastating consequence of a dysregulated NET formation, and (III) the imbalance between NET formation and clearance. We include the role of NET formation in the occlusion of vessels and ducts, in lung disease, in autoimmune diseases, in chronic oral disorders, in cancer, in the formation of adhesions, and in traumatic spinal cord injury. To develop effective therapies, it is of utmost importance to target pathways that cause decondensation of chromatin during exaggerated NET formation and aggregation. Alternatively, therapies that support the clearance of extracellular chromatin are conceivable.

Bibliographical data

Original languageEnglish
ISSN1350-9047
DOIs
Publication statusPublished - 04.2023